Heart Test Laboratories Inc (HSCS)
5.88
-1.09
(-15.64%)
USD |
NASDAQ |
May 20, 16:00
6.06
+0.18
(+3.06%)
After-Hours: 05:09
Heart Test Laboratories Shareholders Equity (Quarterly): 8.634M for Jan. 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 8.634M |
| October 31, 2023 | -1.650M |
| July 31, 2023 | -0.5197M |
| April 30, 2023 | 0.2306M |
| January 31, 2023 | -0.2579M |
| Date | Value |
|---|---|
| October 31, 2022 | 1.083M |
| July 31, 2022 | 2.887M |
| April 30, 2022 | -6.056M |
| January 31, 2022 | -4.102M |
| April 30, 2021 | -1.910M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-6.056M
Minimum
Apr 2022
8.634M
Maximum
Jan 2024
-0.166M
Average
-0.3888M
Median
Shareholders Equity (Quarterly) Benchmarks
| Ainos Inc | 22.68M |
| OpGen Inc | 2.677M |
| Zomedica Corp | 231.90M |
| LENSAR Inc | 31.84M |
| Eargo Inc (DELISTED) | 45.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.80M |
| Total Liabilities (Quarterly) | 2.167M |
| Debt to Equity Ratio | 0.0579 |
| Current Ratio | 5.094 |
| Net Debt Paydown Yield | 1.32% |